Similar articles

• [Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].

  Makarevich NM, Rudoĭ NM. Makarevich NM, et al. Antibiotiki. 1971 Feb;16(2):149-52. Antibiotiki. 1971. PMID: 4326726 Russian. No abstract available.
• [Studies on the effect of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). I. Studies in vitro].

  Ota Y. Ota Y. Kekkaku. 1971 Aug;46(8):295-301. Kekkaku. 1971. PMID: 4328204 Japanese. No abstract available.
• The susceptibility of mycobacteria to rifamide and rifampicin.

  Clark J, Wallace A. Clark J, et al. Tubercle. 1967 Jun;48(2):144-8. doi: 10.1016/s0041-3879(67)80009-6. Tubercle. 1967. PMID: 4293697 No abstract available.
• [Treatment of pulmonary tuberculosis in patients resistant to major drugs with second line drugs].

  Ibarra JP, Piñeyro J, Trenchi A, Tarallo NH, Lanne de Farriols ME, Cuñarro de Gimeno G, Fernández Latorre I. Ibarra JP, et al. Hoja Tisiol. 1967 Jul-Dec;24(1):5-88. Hoja Tisiol. 1967. PMID: 4308762 Review. Spanish. No abstract available.
• Chemotherapeutics with tuberculostatic action.

  Protivinsky R. Protivinsky R. Antibiot Chemother (1971). 1971;17:101-21. doi: 10.1159/000392367. Antibiot Chemother (1971). 1971. PMID: 4376661 Review. No abstract available.